The genetic landscape of mutations in Burkitt lymphoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Genetics

• Publication date

  2012-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.2468PMID 23143597PMCID PMC3674561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Author Manuscript

  2013cited by this paper
• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  2012cited by this paper
• Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin‐fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression

  2011cited by this paper
• Oncogenically active MYD88 mutations in human lymphoma

  2011cited by this paper
• SVA: software for annotating and visualizing sequenced human genomes

  2011influential reference
• Frequent mutation of histone modifying genes in non-Hodgkin lymphoma

  2011cited by this paper
• Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma

  2011cited by this paper
• Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma

  2011cited by this paper
• Integrative Genomics Viewer

  2011influential reference
• Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010influential reference
• Integrating common and rare genetic variation in diverse human populations

  2010cited by this paper
• Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin

  2010cited by this paper
• Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants

  2010cited by this paper
• Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer

  2010cited by this paper
• Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.

  2010cited by this paper
• Fast and accurate long-read alignment with Burrows–Wheeler transform

  2010influential reference
• Circos: an information aesthetic for comparative genomics.

  2009cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants

  2009cited by this paper
• A small cell lung cancer genome reports complex tobacco exposure signatures

  2009cited by this paper
• Design and analysis issues in genome-wide somatic mutation studies of cancer.

  2009influential reference
• Faculty Opinions recommendation of Targeted capture and massively parallel sequencing of 12 human exomes.

  2009cited by this paper
• The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes.

  2009cited by this paper
• E and ID proteins branch out

  2009cited by this paper
• BreakDancer: An algorithm for high resolution mapping of genomic structural variation

  2009influential reference
• Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes

  2009cited by this paper
• Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

  2008cited by this paper
• 1000 Genomes Project

  2008cited by this paper
• 1000 Genomes project

  2008cited by this paper
• Determinants of protein function revealed by combinatorial entropy optimization

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

  2006cited by this paper
• Molecular diagnosis of Burkitt's lymphoma.

  2006cited by this paper
• Phylogenetic trees: visualizing, customizing and detecting incongruence

  2005cited by this paper
• Reverse engineering of regulatory networks in human B cells

  2005cited by this paper
• Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas

  2005cited by this paper
• A census of human cancer genes

  2004cited by this paper
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

  2003cited by this paper
• dbSNP: the NCBI database of genetic variation

  2001cited by this paper
• c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.

  1999cited by this paper
• Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.

  1997cited by this paper
• Amplification and expression of the c-myc oncogene in human lung cancer cell lines

  1983cited by this paper
• Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.

  1983cited by this paper
• A general method applicable to the search for similarities in the amino acid sequence of two proteins.

  1970influential reference
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Uncommon Initial Symptoms in Pediatric Burkitt Lymphoma: Pancreatic and Mandibular Involvement

  2026cites this paper
• A prevalent disease-associated SNP in the human ID3 gene regulates E-protein activity and cellular proliferation

  2026cites this paper
• High-grade/large B-cell lymphoma with 11q aberration: A distinct molecularly defined entity in contemporary pathobiological classifications

  2026cites this paper
• Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience.

  2026cites this paper
• ID2 suppresses multiple myeloma cell proliferation by repressing the activity of the transcription factor TCF3.

  2025cites this paper
• G Protein‐Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers

  2025cites this paper
• Chromatin Regulatory Targets for Anticancer Therapeutics.

  2025cites this paper
• The art of war: using genetic insights to understand and harness radiation sensitivity in hematologic malignancies

  2025cites this paper
• Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment

  2025cites this paper
• A novel clustered-based binary grey wolf optimizer to solve the feature selection problem for uncovering the genetic links between non-Hodgkin lymphomas and rheumatologic diseases

  2025cites this paper
• Audit of B-cell cancer genes

  2025cites this paper
• Primary gastric SMARCA4-deficient carcinosarcoma and sarcomatoid carcinoma: Two case reports

  2025cites this paper
• Circulating tumor DNA in lymphoma: technologies and applications

  2025cites this paper
• Whole genome CRISPR knockout screen reveals ID3 as a key regulator of myeloma cell survival via TCF3 and c-MYC

  2025influential citation
• A Glycerophospholipid Metabolism-Based Prognostic Model Guides Osteosarcoma Therapy

  2025cites this paper
• miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response

  2025cites this paper
• TCF3 and ID3 Regulate TSPAN32 Expression in Burkitt Lymphoma

  2025cites this paper
• Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy

  2025cites this paper
• B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

  2025cites this paper
• A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights

  2025cites this paper
• Distinct structural and numerical chromosome abnormalities determine the MYC status in diffuse large B-Cell lymphoma and help differentiate from Burkitt lymphoma: a cytogenetic data analysis using unsupervised and AI-driven prediction models

  2025cites this paper
• DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

  2025cites this paper
• Novel Molecular Insights and Evolution of Less Toxic Therapeutic Strategies in Burkitt Lymphoma

  2025cites this paper
• Case Report: FAP+ fibroblasts and SPP1+ macrophages in SMARCA2-deficient while SMARCA4-preserved poorly differentiated lung adenocarcinoma: two case reports and multi-omics analysis

  2025cites this paper
• Common origins of autoimmune diseases and lymphoid malignancies.

  2025cites this paper
• MYC as a Target for Cancer Treatment: from Undruggable to Druggable?

  2025cites this paper
• Phosphatidylinositol 3-Kinase Inhibition and Allogeneic Stem Cell Transplantation Can Overcome Chemotherapy Resistance in Refractory Burkitt Lymphoma

  2025cites this paper
• Multi-omics integrative analysis elucidates the molecular characteristics of SMARCA4-deficient lung adenocarcinoma and the derived therapeutic options.

  2025cites this paper
• Tyr1497 in the BRG1 Bromodomain of the SWI/SNF Complex is Critical for the Binding and Function of a Selective BRG1 Inhibitor

  2025cites this paper
• Sporadic Orbital Burkitt Lymphoma in Pediatric Population: A Case Series and Review of the Literature.

  2025cites this paper
• SOX11 in EBV-negative Burkitt lymphoma.

  2024cites this paper
• Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient germinal center B cell responses

  2024cites this paper
• Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma

  2024cites this paper
• B-cell non-Hodgkin lymphomas.

  2024cites this paper
• Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center

  2024cites this paper
• Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation

  2024cites this paper
• Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance

  2024cites this paper
• Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior

  2024cites this paper
• Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases

  2024cites this paper
• Overlapping Gene Expression and Molecular Features in High-Grade B-Cell Lymphoma

  2024cites this paper
• The diagnosis of Burkitt lymphoma: how do pathologists apply criteria in daily practice?

  2024cites this paper
• Burkitt Lymphoma.

  2024cites this paper
• The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma

  2024cites this paper
• MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma

  2024cites this paper
• SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features.

  2024cites this paper
• Clinical Validation of a Targeted Next Generation Sequencing Panel for Lymphoid Malignancies.

  2024cites this paper
• The prognostic value of TP53 mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol

  2024cites this paper
• Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge

  2024cites this paper
• Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies

  2024cites this paper
• Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor

  2024cites this paper
• Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer

  2024cites this paper
• Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.

  2024cites this paper
• Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient Germinal Center B cell responses

  2024cites this paper
• Update: The molecular spectrum of virus-associated high-grade B-cell non-Hodgkin lymphomas.

  2024cites this paper
• Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group

  2024cites this paper
• SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.

  2024cites this paper
• SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.

  2023cites this paper
• Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis

  2023cites this paper
• Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets.

  2023cites this paper
• From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.

  2023cites this paper
• The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects

  2023cites this paper
• GNA13 is a new marker for germinal center-derived B cell lymphomas

  2023cites this paper
• Translocation Tales: Unraveling the MYC Deregulation in Burkitt Lymphoma for Innovative Therapeutic Strategies

  2023cites this paper
• Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 3: Mature Leukemias/Lymphomas

  2023cites this paper
• Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma

  2023cites this paper
• The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target

  2023cites this paper
• Case Report: Gastrointestinal neuroendocrine carcinoma with SMARCA4 deficiency: a clinicopathological report of two rare cases

  2023cites this paper
• GNA13 inhibits glioblastoma metastasis via the ERKs/FOXO3 signaling pathway.

  2023cites this paper
• Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors

  2023cites this paper
• High-grade B-cell lymphoma with 11q aberrations: A single-center study

  2023cites this paper
• Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom.

  2023cites this paper
• Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa

  2023cites this paper
• SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

  2023cites this paper
• SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities

  2023cites this paper
• Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies

  2023cites this paper
• Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

  2023cites this paper
• An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis

  2023cites this paper
• Proteogenomic profiling of high-grade B-cell lymphoma with 11q aberrations and Burkitt lymphoma reveals lymphoid enhancer binding factor 1 as a novel biomarker.

  2023cites this paper
• Emerging roles for heterogeneous ribonuclear proteins in normal and malignant B cells.

  2023cites this paper
• Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.

  2023cites this paper
• Notch signalling: multifaceted role in development and disease

  2023cites this paper
• Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC

  2022cites this paper
• KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders

  2022cites this paper
• Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren’s Syndrome

  2022cites this paper
• SMARCA4 biology in alveolar rhabdomyosarcoma

  2022cites this paper
• Mutations and clinical significance of calcium voltage-gated channel subunit alpha 1E (CACNA1E) in non-small cell lung cancer.

  2022cites this paper
• Epstein-Barr virus: the molecular virology and the associated diseases

  2022cites this paper
• Primary intestinal Burkitt's lymphoma in a Syrian child with a challenging initial presentation: A case report and literature review

  2022cites this paper
• Burkitt lymphoma

  2022cites this paper
• Burkitt lymphoma genomic discovery studies, drivers and validation.

  2022cites this paper
• Lineage switch from acute myeloid leukemia to B‐lymphoblastic lymphoma with an acquired PIK3R1 loss‐of‐function mutation

  2022cites this paper
• SMARCA4: Current status and future perspectives in non-small-cell lung cancer.

  2022cites this paper
• Inhibitor of DNA binding/differentiation proteins as IDs for Pancreatic cancer: Role in pancreatic cancer initiation, development and prognosis.

  2022cites this paper
• Mutation profile of diffuse large B-cell lymphoma with relapses in the central nervous system

  2022cites this paper
• PI3K Isoforms in B Cells.

  2022cites this paper
• Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures.

  2022cites this paper
• EBV-associated diseases: Current therapeutics and emerging technologies

  2022cites this paper
• SMARCA4-associated malignant rhabdoid tumors: case report and literature review

  2022cites this paper
• Burkitt's Lymphoma.

  2022cites this paper
• High urinary CXCL10/Cr with onset of Burkitt lymphoma in a pediatric kidney transplant recipient

  2022cites this paper